| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 79869* | 2013 |
| Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol B Dahlöf, RB Devereux, SE Kjeldsen, S Julius, G Beevers, U de Faire, ... The Lancet 359 (9311), 995-1003, 2002 | 8055 | 2002 |
| Genetic studies of body mass index yield new insights for obesity biology AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ... Nature 518 (7538), 197-206, 2015 | 4967 | 2015 |
| Biological, clinical and population relevance of 95 loci for blood lipids TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ... Nature 466 (7307), 707-713, 2010 | 4173 | 2010 |
| Discovery and refinement of loci associated with lipid levels CJ Willer, EM Schmidt, S Sengupta, GM Peloso, S Gustafsson, S Kanoni, ... Nature genetics 45 (11), 1274, 2013 | 3113* | 2013 |
| Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention … L Hansson, LH Lindholm, L Niskanen, J Lanke, T Hedner, A Niklason, ... The Lancet 353 (9153), 611-616, 1999 | 2847 | 1999 |
| Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study BF Voight, GM Peloso, M Orho-Melander, R Frikke-Schmidt, M Barbalic, ... The Lancet 380 (9841), 572-580, 2012 | 2680 | 2012 |
| Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against … LH Lindholm, H Ibsen, B Dahlöf, RB Devereux, G Beevers, U de Faire, ... The Lancet 359 (9311), 1004-1010, 2002 | 2335 | 2002 |
| Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011 | 2275 | 2011 |
| Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC ... Nature genetics 44 (9), 981-990, 2012 | 2225 | 2012 |
| Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study L Hansson, LH Lindholm, T Ekbom, B Dahlöf, J Lanke, B Scherstén, ... The Lancet 354 (9192), 1751-1756, 1999 | 2203 | 1999 |
| Defining the role of common variation in the genomic and biological architecture of adult human height AR Wood, T Esko, J Yang, S Vedantam, TH Pers, S Gustafsson, AY Chu, ... Nature genetics 46 (11), 1173-1186, 2014 | 2162 | 2014 |
| Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction A Hamsten, G Walldius, A Szamosi, M Blombäck, UD Faire, G Dahlén, ... The Lancet 330 (8549), 3-9, 1987 | 2025 | 1987 |
| Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE) O Raaschou-Nielsen, ZJ Andersen, R Beelen, E Samoli, M Stafoggia, ... The lancet oncology 14 (9), 813-822, 2013 | 2024 | 2013 |
| Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction A Hamsten, B Wiman, U De Faire, M Blombäck New England Journal of Medicine 313 (25), 1557-1563, 1985 | 1837 | 1985 |
| Large-scale association analysis identifies new risk loci for coronary artery disease CARDIoGRAMplusC4D Consortium, P Deloukas, S Kanoni, C Willenborg, ... Nature genetics 45 (1), 25-33, 2013 | 1793 | 2013 |
| New genetic loci link adipose and insulin biology to body fat distribution D Shungin, TW Winkler, DC Croteau-Chonka, T Ferreira, AE Locke, ... Nature 518 (7538), 187-196, 2015 | 1734 | 2015 |
| Genetic variants associated with Lp (a) lipoprotein level and coronary disease R Clarke, JF Peden, JC Hopewell, T Kyriakou, A Goel, SC Heath, S Parish, ... New England Journal of Medicine 361 (26), 2518-2528, 2009 | 1708 | 2009 |
| Genetic susceptibility to death from coronary heart disease in a study of twins ME Marenberg, N Risch, LF Berkman, B Floderus, U de Faire New England Journal of Medicine 330 (15), 1041-1046, 1994 | 1654 | 1994 |
| Effects of long-term exposure to air pollution on natural-cause mortality: an analysis of 22 European cohorts within the multicentre ESCAPE project R Beelen, O Raaschou-Nielsen, M Stafoggia, ZJ Andersen, G Weinmayr, ... The lancet 383 (9919), 785-795, 2014 | 1589 | 2014 |
Björn DahlöfAssoc professor, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg UniversitDirección de correo verificada de mintage.se
